Your browser doesn't support javascript.
loading
Randomized Placebo-Controlled Trial to Evaluate Effects of Eplerenone on Myocardial Perfusion and Function Among Persons With Human Immunodeficiency Virus (HIV)-Results From the MIRACLE HIV Study.
Srinivasa, Suman; Walpert, Allie R; Thomas, Teressa S; Huck, Daniel M; Jerosch-Herold, Michael; Islam, Sabeeh; Lu, Michael T; Burdo, Tricia H; deFilippi, Christopher R; Dunderdale, Carolyn N; Feldpausch, Meghan; Iyengar, Sanjna; Shen, Grace; Baak, Stephen; Torriani, Martin; Robbins, Gregory K; Lee, Hang; Kwong, Raymond; DiCarli, Marcelo; Adler, Gail K; Grinspoon, Steven K.
  • Srinivasa S; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Walpert AR; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Thomas TS; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Huck DM; Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Jerosch-Herold M; Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Islam S; Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Lu MT; Cardiovascular Imaging Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Burdo TH; Department of Neuroscience, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA.
  • deFilippi CR; Division of Cardiology, INOVA Heart and Vascular Institute, Falls Church, Virginia, USA.
  • Dunderdale CN; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Feldpausch M; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Iyengar S; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Shen G; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Baak S; Department of Neuroscience, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA.
  • Torriani M; Division of Musculoskeletal Imaging and Intervention, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Robbins GK; Division of Infectious Disease, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Lee H; Biostatistics Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Kwong R; Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • DiCarli M; Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Adler GK; Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Grinspoon SK; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Clin Infect Dis ; 77(8): 1166-1175, 2023 10 13.
Article en En | MEDLINE | ID: mdl-37243345

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Espironolactona / Infecciones por VIH Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Espironolactona / Infecciones por VIH Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article